These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25014618)

  • 1. Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population.
    Bae JS; Kim JY; Park BL; Kim JH; Kim B; Park CS; Kim BJ; Lee CS; Lee M; Choi WH; Shin TM; Hwang J; Shin HD; Woo SI
    Psychiatr Genet; 2014 Oct; 24(5):225-9. PubMed ID: 25014618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cannabinoid receptor genes (
    Peiró AM; García-Gutiérrez MS; Planelles B; Femenía T; Mingote C; Jiménez-Treviño L; Martínez-Barrondo S; García-Portilla MP; Saiz PA; Bobes J; Manzanares J
    Anxiety Stress Coping; 2020 May; 33(3):256-265. PubMed ID: 32114795
    [No Abstract]   [Full Text] [Related]  

  • 3. Cannabinoid receptor gene polymorphisms and cognitive performance in patients with schizophrenia and controls.
    Ferretjans R; de Souza RP; Panizzutti B; Ferrari P; Mantovani L; de Campos-Carli SM; Santos RR; Guimarães FC; Teixeira AL; Gama CS; Salgado JV
    Braz J Psychiatry; 2022; 44(1):26-34. PubMed ID: 34190825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association of CNR1 gene variations with susceptibility to schizophrenia.
    Seifert J; Ossege S; Emrich HM; Schneider U; Stuhrmann M
    Neurosci Lett; 2007 Oct; 426(1):29-33. PubMed ID: 17881126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.
    Onwuameze OE; Nam KW; Epping EA; Wassink TH; Ziebell S; Andreasen NC; Ho BC
    Psychol Med; 2013 Mar; 43(3):619-31. PubMed ID: 22850347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.
    Ho BC; Wassink TH; Ziebell S; Andreasen NC
    Schizophr Res; 2011 May; 128(1-3):66-75. PubMed ID: 21420833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse.
    Zhang PW; Ishiguro H; Ohtsuki T; Hess J; Carillo F; Walther D; Onaivi ES; Arinami T; Uhl GR
    Mol Psychiatry; 2004 Oct; 9(10):916-31. PubMed ID: 15289816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptor gene polymorphisms and bone mineral density in Korean postmenopausal women.
    Woo JH; Kim H; Kim JH; Kim JG
    Menopause; 2015 May; 22(5):512-9. PubMed ID: 25268406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain.
    Park YM; Choi JE; Kang SG; Koo SH; Kim L; Geum D; Lee HJ
    Hum Psychopharmacol; 2011; 26(4-5):332-7. PubMed ID: 21695734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid receptor type 2 gene is associated with human osteoporosis.
    Karsak M; Cohen-Solal M; Freudenberg J; Ostertag A; Morieux C; Kornak U; Essig J; Erxlebe E; Bab I; Kubisch C; de Vernejoul MC; Zimmer A
    Hum Mol Genet; 2005 Nov; 14(22):3389-96. PubMed ID: 16204352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor.
    Minocci D; Massei J; Martino A; Milianti M; Piz L; Di Bello D; Sbrana A; Martinotti E; Rossi AM; Nieri P
    J Affect Disord; 2011 Nov; 134(1-3):427-30. PubMed ID: 21658778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes.
    Mitjans M; Gastó C; Catalán R; Fañanás L; Arias B
    J Psychopharmacol; 2012 Oct; 26(10):1391-8. PubMed ID: 22826533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients.
    Santoro M; Mirabella M; De Fino C; Bianco A; Lucchini M; Losavio F; Sabino A; Nociti V
    J Neurol Sci; 2017 Aug; 379():298-303. PubMed ID: 28716266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition.
    Sophocleous A; Marino S; Kabir D; Ralston SH; Idris AI
    Aging Cell; 2017 Oct; 16(5):1051-1061. PubMed ID: 28752643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between DISC1 polymorphisms and risk of schizophrenia in a Korean population.
    Bae JS; Kim JY; Park BL; Cheong HS; Kim JH; Shin JG; Park CS; Kim BJ; Lee CS; Kim JW; Lee M; Choi WH; Shin TM; Hwang J; Shin HD; Woo SI
    Psychiatry Res; 2013 Jul; 208(2):189-90. PubMed ID: 23497821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia.
    Tiwari AK; Zai CC; Likhodi O; Voineskos AN; Meltzer HY; Lieberman JA; Potkin SG; Remington G; Müller DJ; Kennedy JL
    Pharmacogenomics J; 2012 Jun; 12(3):260-6. PubMed ID: 21266946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis.
    Clarke TK; Bloch PJ; Ambrose-Lanci LM; Ferraro TN; Berrettini WH; Kampman KM; Dackis CA; Pettinati HM; O'Brien CP; Oslin DW; Lohoff FW
    Addict Biol; 2013 Jul; 18(4):702-8. PubMed ID: 21790903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression: A meta-analysis.
    Kong X; Miao Q; Lu X; Zhang Z; Chen M; Zhang J; Zhai J
    Medicine (Baltimore); 2019 Nov; 98(46):e17403. PubMed ID: 31725603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice Missing Cnr1 and Cnr2 Show Implantation Defects.
    Li Y; Bian F; Sun X; Dey SK
    Endocrinology; 2019 Apr; 160(4):938-946. PubMed ID: 30776303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of an enhancer associated with addictive behaviour within the cannabinoid receptor-1 gene suggests a possible role in alcohol intake, cannabinoid response and anxiety-related behaviour.
    Hay EA; McEwan A; Wilson D; Barrett P; D'Agostino G; Pertwee RG; MacKenzie A
    Psychoneuroendocrinology; 2019 Nov; 109():104407. PubMed ID: 31445429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.